Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 90454d4e4e4afa1a-LAX IP: 116.62.10.13 UTC time: 2025-01-19T08:02:20+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4